What's Happening

You are here

[Issue No. 151] PSS E-Bulletin February 2019

Multimorbidity is associated with polypharmacy which poses a significant burden to patients and the healthcare system. Deprescribing to reduce inappropriate polypharmacy must be done collaboratively with patients to improve their overall quality of life yet maintain control of their chronic conditions. This workshop is dedicated to provide practical clinical advice as well as for those focused on developing, implementing and evaluating deprescribing programs at different levels of the healthcare system.

In accordance with Article 7(1) of the Pharmaceutical Society of Singapore Constitution, notice is hereby given that the 113th Annual General Meeting of the Society will be held on 23rd March 2019.

In this issue of ‘In conversation with a specialty pharmacist’, we interviewed Ms Laurane Lim from KTPH who provides community care services to patients discharged from the hospital.

NUS Saw Swee Hock School of Public Health is organising the Public Health Thought Leadership Dialogue: ‘Challenges to Current and Future Tobacco Control’ on 6 March 2019, 3:00pm – 4:30pm, Lecture Theatre 36, Level 3, Block MD6, National University of Singapore. The dialogue will feature internationally renowned tobacco control and advocacy expert, Prof Kenneth Warner, who is the Avedis Donabedian Distinguished University Professor Emeritus of Public Health, Professor Emeritus of Health Management & Policy, and Dean Emeritus at the University of Michigan School of Public Health. Prof Warner will be examining and discussing with a panel of other experts challenges to current and future tobacco control strategies and measures.

On behalf of the Singapore Cardiac Society, it is our great pleasure to announce that the Society’s 31st Annual Scientific Meeting will be held from 5th – 7th April 2019 at the Grand Copthorne Waterfront Hotel.  For the first time, there will be a dedicated pharmacy track helmed by pharmacists. It incorporates a mini debate on direct oral anticoagulants, updates on the national collaborative prescribing program, as well as tips and tricks when prescribing some of the newer classes of cardiovascular drugs.